Total Neoadjuvant Therapy vs Standard Therapy in Locally Advanced Rectal Cancer
Author:
Affiliation:
1. Division of Medical Oncology, Department of Medicine, Kansas University Medical Center, Westwood
2. Department of Internal Medicine, Icahn School of Medicine/Mount Sinai West and Morningside, New York, New York
Publisher
American Medical Association (AMA)
Subject
General Medicine
Link
https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2774248/kasi_2020_oi_200948_1607525680.52216.pdf
Reference42 articles.
1. Cancer statistics, 2020.;Siegel;CA Cancer J Clin,2020
2. Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study.;Bosset;Lancet Oncol,2014
3. No benefit of adjuvant fluorouracil leucovorin chemotherapy after neoadjuvant chemoradiotherapy in locally advanced cancer of the rectum (LARC): long term results of a randomized trial (I-CNR-RT).;Sainato;Radiother Oncol,2014
4. Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging–defined poor-risk rectal cancer.;Chau;J Clin Oncol,2006
5. Rectal Cancer, version 2.2018, NCCN clinical practice guidelines in oncology.;Benson;J Natl Compr Canc Netw,2018
Cited by 225 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Optimizing Rectal Cancer Treatment: A Path Towards Personalization;Annals of Oncology;2024-10
2. The Role of Predictive and Prognostic MRI-Based Biomarkers in the Era of Total Neoadjuvant Treatment in Rectal Cancer;Cancers;2024-09-09
3. Accuracy of Baseline Magnetic Resonance Imaging for Staging Rectal Cancer Patients Proceeding Directly to Surgery;Journal of Surgical Oncology;2024-09-05
4. A patient-designed integrative oncology intervention for stage IV locally recurrent rectal cancer: A case report;EXPLORE;2024-09
5. Brazil-TNT: A Randomized Phase 2 Trial of Neoadjuvant Chemoradiation Followed by FOLFIRINOX Versus Chemoradiation for Stage II/III Rectal Cancer;Clinical Colorectal Cancer;2024-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3